Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission
Completed · Phase 3
Conditions studied: Leukemia
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of bone marrow transplantation using untreated or treated bone marrow in treating patients with acute leukemia in first or second remission.
Key facts
- Study ID
- NCT00002534
- Run by
- Memorial Sloan Kettering Cancer Center
- Starts
- 1993-05-01
- Expected to finish
- 2003-04-01
- Last updated by the study team
- 2013-06-26
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.